HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Buserelin Acetate

HCID 50224
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
68630-75-1
Standard SMILES
CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1
InChIKey
PYMDEDHDQYLBRT-DRIHCAFSSA-N
Molecular formula
C62H90N16O15
Average molar mass
1,299.5 g/mol
Monoisotopic mass
1,298.67715623

Overview

Buserelin acetate is an organic molecular entity.

Names & identifiers

Preferred name
Buserelin Acetate
IUPAC
acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
English name
Buserelin Acetate
Molecular formula
C60H86N16O13.C2H4O2
Molecular weight
1299.48

Names & synonyms

Buserelin acetate68630-75-1SuprecurReceptalBuserelin monoacetateConceptalHOE 766MPHOE-766NSC-72517613U86G7YSPDTXSID30218712Suprefact Depot
Show more names
FusetEstoMalItorelinhoe766mpSupreMonBuserecurSuprafactSuprecur-MP
Profact DepotSuprefact FlakonBSRL AcetateAcetate, BuserelinRefChem:54578HOE766DTXCID80141203D-Ser (Bu(t))(6) Pro(9) NEt LHRH Acetate

Database identifiers

CAS
68630-75-1
PubChem CID
50224
DTXSID
DTXSID30218712
ChEMBL
CHEMBL2106198
ChEBI
CHEBI:31324

Properties

Computed structural propertiesFilling in

Topological polar surface area
478 Ų
Hydrogen bond donors
16
Hydrogen bond acceptors
17
Rotatable bonds
33
Heavy atoms
93
Formal charge
0
Complexity
2,480

Experimental & physicochemical properties

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List

Physicochemical properties

Melting point
186 · 186-188°C
storage temp.
-20 °C · -20°C
solubility
DMSO (Slightly), Methanol (Slightly), Water (Slightly)
form
Solid
color
White to Off-White
Stability
Hygroscopic
InChIKey
PYMDEDHDQYLBRT-DRIHCAFSSA-N
FDA UNII
13 U86G7YSP · 13U86G7YSP
UNSPSC Code
51111800 · 51111800
NACRES
32 · NA.32
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
302 · H302-H360

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Regulatory InformationBuserelin acetate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Safety data

PPE
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
rtecs
OK6370000
risk_code
60
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
hazard_code
T
safety_code
53-22-36/37/39-45
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard statements
H302-H360
Hazard Classifications
Acute Tox. 4 OralRepr. 1B
Precautionary statements
P201-P301+P312+P330-P308+P313

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationCompounds which increase the capacity to conceive in females.
Applications · 2 items

DescriptionBuserelin acetate is a potent analog of the hypothalamic hormone, luteinizing hormone-releasing hormone (LH-RH). Chronic administration of higher doses of buserelin desensitizes the pituitary, resulting in a decreased production of luteinizing hormone (LH), follicle stimulating hormone (FSH), and eventually sex steroids (testosterone in males and estradiol in females). Initial approval is for use in achieving medical castration in the treatment of advanced prostate cancer. It has also been investigated for the treatment of endometriosis, leiomyoma, precocious puberty, advanced breast cancer and infertility.

UsesGondadotropin-releasing hormone agonist, used to treat hormone-responsive cancers such as prostate and breast cancer. Synthetic nonapeptide agonist analog of LH-RH. Antineolpastic (hormonal).

Additional notes

DefinitionChEBI: Buserelin acetate is an organic molecular entity.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
13U86G7YSP
Precautionary statements
201 · P201-P301+P312+P330-P308+P313
PPE
3 · Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
T
Risk Statements
60 · 60
Safety Statements
53 · 53-22-36/37/39-45
WGK Germany
3 · 3
RTECS
6370000 · OK6370000
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
4 OralRepr · Acute Tox. 4 OralRepr. 1B